Siltuximab (CNTO 328): a promising option for human malignancies

• Main Authors: Chen R (Author), Chen B (Author)
• פורמט: ספר
• יצא לאור: Dove Medical Press, 2015-07-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Runzhe Chen, Baoan Chen Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People’s Republic of China Abstract: Siltuximab (CNTO 328) is a promising antibody-drug conjugate targeting cytokine interleukin-6 (IL-...